O0C.F Med Life S.A.
- Market cap
- EUR 985M
- P/E
- -
- P/B
- 11.13x
- ROE
- -32.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is O0C.F undervalued?
Graham numberThe Graham number of Med Life S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Med Life S.A. fundamental analysis
No fundamental analysis for Med Life S.A. yet.
Med Life S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Med Life S.A.
Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides l…
Full company profileMed Life S.A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Med Life S.A. annual financial statements (RON; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.43B | 1.80B | 2.21B | 2.72B | 3.54B |
| Gross Profit | 859M | 1.04B | 1.28B | 1.57B | 1.99B |
| Operating Income | 177M | 99.1M | 94.2M | 152M | 187M |
| EBITDA | 271M | 236M | 278M | 388M | 263M |
| Net Income | 103M | 32.2M | 3.68M | 25.5M | -150M |
| EPS | 0.20 | 0.06 | 0.01 | 0.05 | -0.28 |
| Balance Sheet | |||||
| Total Assets | 1.42B | 2.15B | 2.64B | 3.02B | 3.36B |
| Total Liabilities | 1.04B | 1.67B | 2.14B | 2.52B | 2.83B |
| Shareholders' Equity | 338M | 417M | 415M | 433M | 458M |
| Cash & Short-term Investments | 136M | 89.1M | 100M | 113M | 159M |
| Cash Flow | |||||
| Operating Cash Flow | 227M | 185M | 184M | 276M | 282M |
| Capital Expenditure | 96.9M | 169M | 220M | 248M | 228M |
| Free Cash Flow | 130M | 15.3M | -36.4M | 28.1M | 54.6M |
| Ratios | |||||
| ROE | 30.3% | 7.7% | 0.9% | 5.9% | -32.9% |
| ROA | 7.2% | 1.5% | 0.1% | 0.8% | -4.5% |
| Net Profit Margin | 7.2% | 1.8% | 0.2% | 0.9% | -4.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Med Life S.A. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | RON 3.67M | 0.01 | 3.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns Med Life S.A.
- Insiders 48.53%
- Institutions 26.57%
- Public & others 24.90%
- Shares outstanding 531M
- Free float 337M
Med Life S.A. company profile
- Company name
- Med Life S.A.
- Ticker
- O0C.F
- ISIN
- ROMEDLACNOR6
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Employees
- 6,525
- Fiscal year end
- December
- Address
- 365 Calea Grivitei, Bucharest, Romania
- Phone
- 40 749 999 023
- Website
- medlife.ro
About Med Life S.A.
Med Life S.A., a private healthcare provider, provides integrated medical services through its clinics and hospitals in Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging tests; day hospitalization services; hospitalization and surgical treatment services; medical and surgical specialties; maternal and child health dedicated services; and stem cell bank. It also provides laboratory services, such as biochemistry, pathological anatomy, molecular biology and genetics, hematology, immunology, microbiology, cytology, and toxicology; healthcare packages; a range of dental services; and fitness services and wellness facilities through the Sweat Concept network and Sanopass platform. In addition, the company is involved in the development of building projects; insurance broker; rental activities; and distribution and retail sale of pharmaceutical products in specialized stores. Med Life S.A. was incorporated in 1996 and is headquartered in Bucharest, Romania.
Med Life S.A. management
5- Mr. Mihail MarcuChairman & CEO · born 1970
- Ms. Oana-Alina Irinoiu-TituCFO & Investor Relations Manager · born 1993
- Mr. Nicolae MarcuChief Healthcare & Operations Officer and Director · born 1968
- Mr. Radu PetrescuHuman Resources Director · born 1980
- Mr. Dorin PredaDeputy CEO, Chief Finance, Treasury & Director · born 1976